Related content

Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints

By Oh W.K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 229-234

Elsevier

Access to resources Recommend Favorite

Radiotherapy in the management of prostate cancer after radical prostatectomy

By Bartkowiak Detlef   Bottke Dirk   Wiegel Thomas  

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 669-679

Future Medicine

Access to resources Recommend Favorite

The Role of Radical Prostatectomy in Patients with Prostate Cancer

By  

Journal of the National Cancer Institute, Vol. 105, Iss. 8, 2013-04 ,pp. : 1-1

Oxford University Press

Access to resources Recommend Favorite

Neoadjuvant hormonal therapy and radical prostatectomy in the treatment of clinical stage T3 cancer of the prostate

By Katz G.   Parson J.T.   Wajsman Z.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 6, 1998-11 ,pp. : 203-209

Elsevier

Access to resources Recommend Favorite

Molecular staging by RT-PCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer

By Mitsiades Constantine   Lembessis Peter   Sourla Antigone   Milathianakis Constantine  

Clinical and Experimental Metastasis, Vol. 21, Iss. 6, 2004-10 ,pp. : 495-505

Springer Publishing Company

Access to resources Recommend Favorite